Click here for printer friendly page
Warburg Pincus backs new private investment firm Constitution Medical Investors23/06/2008. Source: AltAssets. 
 Warburg Pincus is backing the launch of a new firm to acquire healthcare-related platform technologies and companies. Constitution Medical Investors, as the new Boston-based firm is called, will be led by senior healthcare executives Patrick Sullivan and Daniel Levangie.
Sullivan is the former president and CEO of Cytyc Corporation. Until recently he served as executive chairman of Hologic, which acquired Cytyc in October 2007.
Levangie previously was executive vice president of Cytyc and president of Cytyc's Surgical Products Division. He currently serves as a director of Hologic.
Sullivan said, 'We are proud of our track record of success in creating value in the healthcare marketplace, and we are very pleased to partner with Warburg Pincus, which will provide us with world-class support and resources that will allow us to once again make a real difference in improving medical care.'
Bess Weatherman, the Warburg Pincus managing director who leads the firm's investment activities in medical devices and healthcare services, added, 'We are very excited to join Pat and Dan in the formation of CMI, and are eager to work with them in the identification of opportunities that will leverage their deep experience and industry know-how.'
Warburg Pincus has approximately $35bn of assets under management. Current investments in the healthcare sector include Alita Pharmaceuticals, Bausch & Lomb, Euromedic, Inspire Pharmaceuticals, InterMuneMedical Staffing, Neurogen Corporation, Prestwick Pharmaceuticals, Sunesis Pharmaceuticals, Tornier and ZymoGenetics.
Copyright © 2008 AltAssets
|
